GE vs ISRG: Which Is the Better Buy?

Side-by-side comparison of GE Aerospace and Intuitive Surgical, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-16.
GE Aerospace Β· Industrials
$360.35
-25.9% upside to fair value
Grade D High Quality
VS
Intuitive Surgical, Inc. Β· Healthcare
$388.97
+45.0% upside to fair value
Grade B High Quality
QuantHub Verdict
ISRG has more upside to fair value (+45.0%). GE trades at a lower forward P/E (42.3x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric GE ISRG
Current Price $360.35 $388.97
Fair Value Estimate $267.03 $564.01
Upside to Fair Value -25.9% +45.0%
Market Cap $376.5B $137.8B
Forward P/E 42.3x 46.5x
EV / EBITDA 33.4x 31.4x
Price / Sales 7.8x 13.0x
Price / FCF 50.5x 48.6x
Revenue Growth YoY +21.1% +23.0%
Gross Margin 36.1% 66.3%
Operating Margin 21.0% 30.5%
Return on Equity 46.2% 17.0%
Dividend Yield 0% 0%
FCF Yield 1.98% 2.06%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
GE β€” GE Aerospace
GE Aerospace operates in the Industrials sector within the Aerospace & Defense industry, delivering high-quality aerospace products and services. The business demonstrates strong fundamentals with a high return on equity of 46.2%, robust revenue growth of 21.1% in the most recent quarter, and solid earnings growth of 16.9% in the same period. Margins are healthy, with a gross margin of 36.1%, ope…
ISRG β€” Intuitive Surgical, Inc.
Intuitive Surgical, Inc. operates in the healthcare sector, specializing in medical devices with a strong focus on robotic-assisted surgery systems. The company demonstrates high business quality with a durable competitive moat supported by a 17.0% return on equity, robust gross margin of 66.3%, and solid operating margin of 30.5%. Revenue and earnings growth in the most recent quarter were impre…
Accumulation Zones
Metric GE ISRG
Zone Low $200.27 $423.01
Zone High $226.98 $479.41
In Buy Zone? No Yes
← GE Research    ISRG Research β†’    All Research